Following the collapse of the Build Back Better Act (BBBA), it remains unclear whether Congress will pass drug pricing legislation. While it is still possible for Congress to act on separate components of the BBBA (including drug pricing) via reconciliation, there is less insight into how exactly Democrats plan to move forward on these legislative priorities. It has remained WHG’s... Read More
WHG - Weekly, March 7-11
The deadline to fund the government for fiscal year (FY) 2022 is this Friday, March 11. Democrats are pushing to include COVID-19 supplemental funding in the FY 2022 appropriations omnibus, along with Ukraine assistance. “Democrats have made a reasonable global offer to Republicans and it is my hope that we will reach an agreement very soon so that we can... Read More
WHG - Weekly, February 28-March 4
This week’s main event is President Biden’s first State of the Union address tomorrow evening. While the President’s remarks will have a significant focus on national security, we anticipate his speech will also touch on the Biden Administration’s COVID-19 response and health care priorities. Biden may provide some direction to lawmakers on which health policies of the Build Back Better... Read More
WHG - Weekly, February 22-25
With Congress in recess this week, we look ahead to what is underway on the administrative front – including changes to electronic prior authorization, Medicare payment updates, Medicare Advantage (MA) and Part D Advance Notice, and modifications to Medicare enrollment. Additionally, we highlight key activities and dates related to the unwinding of the Medicaid continuous coverage requirement... Read More
WHG - Weekly, February 14-18
Senate Votes A third continuing resolution (CR) appears to be the charm for fiscal year (FY) 2022 appropriations. On the heels of an agreed-to “bipartisan appropriations framework,” the Senate is expected to pass the House-approved (272-162) stopgap funding extension before the current CR expires on February 18. Lawmakers will then have until March 11 to negotiate and finalize all 12... Read More
WHG - Roundup of Recent Telehealth Policy
Federal attention on telehealth continues to mount. This is true especially as uncertainty builds around when the COVID-19 public health emergency (PHE) will end, which would mark the end of many telehealth flexibilities absent further congressional action (though the Administration may allow any flexibilities to persist for up to an additional 60 days following the end of the PHE). The... Read More
WHG - Weekly, February 7-11
Without an agreement on a fiscal year (FY) 2022 spending, and with the February 18 deadline of the second continuing resolution (CR) approaching, top appropriators are considering a third CR with a March 11 expiration. The protracted bipartisan talks over topline spending numbers have stalled the finalization of all 12 appropriations bills. The House is expected to vote on a... Read More
WHG - Weekly, January 31-February 4
While congressional Democrats continue to negotiate a scaled down version of the Build Back Better Act (BBBA), lawmakers are homing in on other key legislative priorities. This week, committees in both chambers will hold hearings on an array of health policy issues – including mental health, Medicare financing, Food and Drug Administration’s (FDA) user fee programs, public health, and broadband... Read More
WHG - Weekly, January 24-28
With major health care legislation on hold as congressional Democrats figure out how to pass “big chunks” of the Build Back Better Act (BBBA), we look ahead to statutory cliffs and potential legislative vehicles to watch as well as anticipated rulemaking from the Biden Administration in 2022. A fuller account of WHG’s 2022 Legislative & Regulatory Outlook is available here... Read More
WHG - 2022 Legislative and Regulatory Outlook - Excel Version
As a companion tool to our Legislative and Regulatory Outlook, WHG has also developed an excel-based version that allows for greater sortability across a range of variables (including by agency and health policy area)... Read More
WHG - 2022 Legislative and Regulatory Outlook
WHG has developed its Legislative and Regulatory Outlook for 2022, based largely on changes reflected in the Administration's recently released Fall 2021 Unified Agenda. As in previous versions of our annual outlook, we provide a comprehensive line-up of key federal health care policy developments we expect to see throughout the course of the coming year and their approximate timing. We... Read More
WHG - Weekly, January 18-21
With the expiration of the continuing resolution (P.L. 117-70) funding the federal government one month away (February 18), top congressional appropriators appear to be nearing a deal on a fiscal year (FY) 2022 omnibus government funding bill. Whether a COVID-19 supplemental package will be bundled with the FY 2022 funding bill remains an open question, as congressional Democrats wait for... Read More
WHG - Weekly, January 10-14
COVID-19 The Biden Administration faces a crucial week, as President Biden and top health officials try to ensure public confidence in the administration’s COVID-19 response, especially as the Centers for Disease Control and Prevention (CDC) faces harsh criticism over its new isolation and quarantine guidelines for the general population and schools. The President is scheduled to deliver remarks on the... Read More
WHG - Weekly, January 3-7, 2022
Congressional Democrats return with the same to-do list but with a more tenuous political landscape. Following Sen. Joe Manchin’s (D-WV) announcement that he will not support the Build Back Better Act (BBBA) as currently proposed, Democrats will work to revise the package to a more pared down version that may possibly exclude some of its more contentious elements. As another... Read More
WHG - Weekly, December 13-17
Please note that Wynne Health Group will be closed for the winter holidays beginning Mon., Dec. 20 through Fri., Dec. 31, reopening Mon., Jan. 3, 2022. We are grateful for your continued partnership and look forward to our work together in the new year. Happy Holidays! Reconciliation Over the weekend, the Senate Finance (SFC) and Health, Education, Labor and Pensions... Read More
WHG - Weekly, December 6-10
This week, the House may vote on legislation to delay several Medicare payment cuts that would take effect on January 1, 2022. The bill may include: Extending the temporary 3.75 percent increase to the physician fee schedule; Delaying cuts as large as 15 percent to clinical laboratory tests; and Extending the moratorium on 2 percent Medicare sequester. The House is... Read More
WHG - Weekly, November 29-December 3
Congress enters its busiest season with less than 10 scheduled working days before lawmakers adjourn on December 13. Fiscal Year 2021 funding – With the current continuing resolution set to expire on December 3, lawmakers are expected to vote on a new CR to fund the government at least until mid-December, though it could be extended through late January. Debt... Read More
WHG - Weekly, November 15-19
Today, President Biden will sign the Infrastructure Investments and Jobs Act (H.R. 3684) into law. The bipartisan infrastructure deal provides $65 billion for broadband infrastructure to expand access to reliable high-speed internet, which is widely recognized as a social determinant of health (see our recent Issue Brief on Medicare telehealth coverage and health equity for a discussion on the intersection... Read More
WHG - Weekly, November 8-12
This week, President Biden will sign the Infrastructure Investments and Jobs Act (H.R. 3684) into law. Meanwhile, House Democrats are waiting for the Congressional Budget Office (CBO) to score the Build Back Better Act (BBBA, H.R. 5376). Five moderate Democrats vowed to vote for the BBBA “in its current form” if the CBO score aligns with the estimates presented by... Read More
WHG - Weekly, November 1-5
Democrats appear to be getting close to a compromise on prescription drug pricing reforms – including versions of Medicare drug price negotiation, Part D redesign, inflation rebates that are more moderate than originally proposed in H.R. 3 (WHG summary of the most pertinent drug pricing proposal provisions in the 117th Congress). We could see the House vote on the Build... Read More
- « Previous Page
- 1
- …
- 7
- 8
- 9
- 10
- 11
- …
- 20
- Next Page »